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Determination of the type and origin of the body fluids found 
at a crime scene can give important insights into crime scene 
reconstruction by supporting a link between sample donors 
and actual criminal acts. For more than a century, numerous 
types of body fluid identification methods have been 
developed, such as chemical tests, immunological tests, 
protein catalytic activity tests, spectroscopic methods and 
microscopy. However, these conventional body fluid 
identification methods are mostly presumptive, and are carried 
out for only one body fluid at a time. Therefore, the use of a 
molecular genetics-based approach using RNA profiling or 
DNA methylation detection has been recently proposed to 
supplant conventional body fluid identification methods. 
Several RNA markers and tDMRs (tissue-specific differentially 
methylated regions) which are specific to forensically relevant 
body fluids have been identified, and their specificities and 
sensitivities have been tested using various samples. In this 
review, we provide an overview of the present knowledge and 
the most recent developments in forensic body fluid 
identification and discuss its possible practical application to 
forensic casework. [BMB Reports 2012; 45(10): 545-553]
INTRODUCTION
Biological samples found at the crime scenes play pivotal roles 
in forensic investigations by providing valuable evidence (1). 
Since the DNA profile of every individual is considered to be 
unique (except in the case of identical twins), DNA typing of 
biological samples can prove whether a suspect was involved 
in a crime, and even can exonerate innocent persons who 
have been wrongfully convicted (2). Besides, determination of 
the type and origin of biological samples found at crime 
scenes can provide important clues for crime scene re-
constructions by supporting a link between sample donors and 
actual criminal acts. The presence of certain body fluids can 
be used as excellent indicators of the sequence of events 
which occurred. For example, blood stains can indicate some 
form of physical struggle, assault or murder, and detection of 
semen or vaginal fluid can indicate the involvement of some 
form of sexual encounter or assault. The common body fluids 
found at crime scenes are blood, semen, saliva, vaginal fluid, 
urine, and sweat.
　When a potential body fluid is discovered at a crime scene, 
a particular form of light or chemical addition may be required 
to visualize the stain (3). Presumptive tests are initially used to 
give some indication as to the identity of the substance, and 
further confirmatory tests are then conducted to confirm the 
origin of the sample (2). For more than a century, numerous 
types of analysis methods have been developed for inves-
tigation of forensically relevant body fluids. Techniques which 
are currently used for forensic body fluid identification include 
chemical tests, immunological tests, protein catalytic activity 
tests, spectroscopic methods, and microscopy. Some of these 
methods are presumptive tests which are used as screening 
tests, such as the luminol and Kastle-Meyer test for blood. 
Others are confirmatory test that will conclusively identify the 
presence of certain body fluid, such as the microscopic identi-
fication of sperm cells (4, 5). Most catalytic, enzymatic and im-
munologic tests which have been used for presumptive or con-
firmatory methods suffer from several limitations, such as low 
specificity, lack of sensitivity, sample destruction, instability of 
biomolecule assayed, or incompatibility with downstream in-
dividual identification assays although they have certain ad-
vantages (2). 
　Recent advances in forensic genetics have led to the devel-
opment of several new methods, and the majority of these 
methods involve the detection of specific messenger RNA 
(mRNA) and micro RNA (miRNA) expressions, as well as dif-
ferential DNA methylation patterns. Especially, recent ap-
proaches based on tissue-specific mRNA or miRNA expression 
have been proved to be useful because of their high tissue spe-
cificity to forensically relevant body fluids. However, ubiq-
uitously present ribonucleases are detrimental to mRNA stabil-
ity, and RNA typing requires additional sample material, un-
less the RNA is co-extracted with DNA. More recently, 
DNA-methylation based assays, which identify differential 
DNA methylation profiles of different cell or tissue types, have 
been proposed as a promising new method for distinguishing 
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between different types of body fluids because of their high 
specificity and fit with current forensic casework application. 
　This review briefly describes current and previous techni-
ques of body fluid identification that are being used in forensic 
laboratories, and evaluates the advantages and disadvantages 
of each method. We will also focus on new methods of identi-
fication that have been developed in the past decade, specifi-
cally mRNA based assays, miRNA based assays and DNA 
methylation based assays. The review concludes with a dis-
cussion of the potential application of these new methods for 
forensic case works.
CURRENT TECHNIQUES
Alternate light source methods
The simplest way to detect body fluid stains that are difficult to 
see with the naked eye is to use an alternate light source (ALS) 
such as ultraviolet light. Because it is a routine procedure to 
search a crime scene for latent stains of body fluids using ALS, 
there are various commercial ALS devices, such as Wood’s 
Lamp (WL), specific for semen detection. WL which emits 
wavelengths ranging about 320-400 nm is safe and handy, but 
the specificity is somewhat low, thereby carrying a high risk of 
false positive results for other fluids (6). Another ALS device, 
BluemaxxTM BM 500 demonstrated 100% sensitivity to semen 
stains (7), and PolilightⓇ can detect several body fluids, includ-
ing semen (8). A newly developed device, LumatecⓇ Superlight 
400 emits light from 320 to 700 nm and is able to detect stains 
both in darkness and in daylight (9). Using this device, semen 
was best detected using a range of 415-490 nm, and saliva was 
also detectable in 60% of cases. However, poor results were 
obtained when it was applied to dark fabrics and to fabrics 
which had been washed, although it had been reported that dif-
ferent types of fabrics showed similar results (9, 10).
Chemical tests
Chemical tests are usually based on the color change or chem-
iluminescence of a particular reagent when it comes into con-
tact with a particular body fluid. Luminol is frequently used in 
identifying blood stains, particularly when the perpetrator has 
attempted to clean up the blood, thus rendering it invisible to 
the naked eye (11, 12). Due to the emission of light as a result 
of an oxidation of luminol enhanced by iron in hemoglobin 
and its derivatives in blood, trace amounts of blood can be de-
tected by chemiluminescence of a blue-green color (13, 14). 
However luminol has been known to react with other sub-
stances, including copper containing chemical compounds, 
certain bleaches, saliva, and various animal and vegetable 
proteins. The luminol test remains popular due to the rela-
tively high sensitivity and specificity in comparison with other 
screening tests. However, it is limited to use in dark environ-
ments and also has disadvantages regarding the duration of il-
lumination (about 30 seconds) and sometimes has detrimental 
effects on subsequent DNA analysis (15-17). BluestarⓇ Foren-
sic is another latent blood stain reagent based on chemilu-
minescence, and it gives more sensitive and stable results 
without damaging DNA and thereby allows for subsequent 
genotyping of stains (16, 18).
Catalytic tests
Catalytic methods are based on the enzyme activity which cat-
alyzes the reaction of a variety of substrates to produce visible 
color changes. There are several different catalytic tests which 
are commonly used to presumptively identify blood based on 
the peroxidase-like activity of heme group (13, 14). The heme 
group of hemoglobin possesses a peroxidase-like activity 
which catalyzes the breakdown of hydrogen peroxide, and the 
oxidizing species formed in this reaction can then react with a 
variety of substrates to produce a color change (19). Among 
the substrates in common use are benzidine and various sub-
stituted benzidines, ortho-tolidine, leucomalachite green, leu-
cocrystal violet and phenolphthalein, also known as the 
Kastle-Meyer test (20, 21).
　The most commonly utilized of these tests is the benzidine 
test, where the presence of blood is indicated by blue colored 
products. However, there are several substances which can 
generate false positives for this test, such as chemical oxidants 
and fruit and vegetable peroxidases (22). Moreover, benzidine 
is known as a carcinogen (23), and accordingly this has largely 
been replaced by tests using phenolphthalein/hydrogen 
peroxide. The test using phenolphthalein is also known as the 
Kastle-Meyer test, which is a very popular presumptive test for 
blood. The stain in question is collected with a swab or filter 
paper, and phenolphthalin reagent and hydrogen peroxide are 
then applied to the sample. If the sample contains hemoglo-
bin, a result produces a pink coloring only after the addition of 
hydrogen peroxide, by oxidation of phenolphthalin into 
phenolphthalein. Although false-positives are reported in the 
presence of chemical oxidants and vegetable peroxidases, the 
test can detect blood as dilute as 1 part in 10,000. In addition, 
this test is nondestructive to the sample, which can then be 
kept and used in further tests, including DNA analysis (20, 21, 
24, 25).
　The acid phosphatase (AP) test is one of the most common 
tests for semen detection. AP is an enzyme secreted by the 
prostate gland that is present in large amounts in seminal fluid 
(26). The level of AP activity is 500 to 1,000 times higher in 
human semen than in any other body fluid. AP can catalyze 
the hydrolysis of phosphates, which results in the formation of 
a product that will react with the color developer (27). 
Therefore, in the presence of Alpha-Naphthyl acid phosphate 
and Brentamine Fast Blue, AP will produce a dark purple color 
(27). However, the test for AP is highly presumptive because 
vaginal secretions and other body fluids also contain detect-
able levels of this enzyme (13).
　A catalytic test for the detection of saliva is based on the en-
zymatic activity of alpha-amylase. Saliva is rich in alpha-amy-
lase, an enzyme that hydrolyses polysaccharides into smaller 
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sugar molecules (28). The starch-iodine detects the alpha-amy-
lase activity owing to the fact that iodine reacts with the starch 
producing a purple black color. In the presence of the amy-
lase, the intensity of color decreases as starch is broken down 
by any amylase present (2). Another method for the detection 
of alpha-amylase is the PhadebasⓇ test, which includes amylo-
pectin-procion red instead of starch-iodine (29, 30). This test is 
relatively cheap, quick, and highly sensitive, but false positive 
results were also observed in hand cream, face lotion, urine, 
and feces (29, 30). Additionally, there are two different forms 
of alpha-amylase in the human body; AMY1 found in saliva, 
breast milk and perspiration and AMY2 found in the pancreas, 
semen and vaginal secretions. Although AMY1 is found pre-
dominantly in saliva compared with other types of body fluids, 
the two variants are almost indistinguishable in terms of their 
enzyme activity. Thus, detection of the activity of alpha-amy-
lase can only give presumptive information because it is not 
exclusive to saliva (2, 27). 
Immunological tests
Many traditional tests used in forensic science are immuno-
logical tests that are based on specific antibody-antigen 
reaction.
　The OneStep ABAcardⓇ HemaTrace test strip is an im-
munochromatographic test for the detection of human blood 
(2, 14, 25). If human hemoglobin is present in the sample, it 
will combine with a mobile monoclonal anti-human hemoglo-
bin antibody in the test strip. Any antibody-antigen complex 
formed then migrates through an absorbent membrane to the 
test area. When the human hemoglobin concentration is 
above a certain minimum detection limit (0.05 μg/ml), the 
pink dye becomes visible in the test region. The results have 
shown the OneStep ABAcardⓇ HemaTrace to be a highly sen-
sitive, convenient, and rapid test for the identification of hu-
man blood both in the laboratory and at crime scenes. 
　The most commonly used confirmatory test for semen de-
tection beyond microscopic identification of the sperm cells is 
a test based on the detection of prostate specific antigen (PSA) 
(31). PSA is produced in high amounts by the male prostate 
gland, and is even detected in the semen from azoospermic 
males (27, 32). Commercial test kits that depend on anti-
body-antigen reaction are currently widely used for PSA 
detection. One of the most popular commercial kits, the 
OneStep ABAcard® PSA, also uses the technique of a mobile 
monoclonal anti-human PSA antibody which binds to human 
PSA and migrates along the strip, forming a visible line in its 
path (33, 34). However, studies have shown that PSA can also 
be found in very low levels in other body fluids, such as fe-
male urine and breast milk (35, 36). 
EMERGING TECHNIQUES
Messenger RNA profiling methods
During the last decade, RNA analysis has emerged as a prom-
ising new tool for forensic investigation applications, such as 
inferences about post-mortem intervals and wound age (37). 
Additionally, recent development in forensic genetics revealed 
that tissue-specific RNA expression can be used for human 
body fluid identification. 
　RNA is notorious for its instability because of the ubiq-
uitously present ribonucleases. However, recent studies have 
reported that RNA isolated from some forensic stains showed 
unexpectedly high stability. Using whole-genome gene ex-
pression on aged blood and saliva stains, Zubakov et al. (38) 
identified blood and saliva specific messenger RNA (mRNA) 
markers that showed stable expression patterns in stains after 
up to 180 days of storage, and some of these markers showed 
successful and reliable amplification in much older stains, 
such as 16 year-old blood stains (39). Setzer et al. (40) con-
ducted a more comprehensive study on mRNA stability in for-
ensic samples. They exposed biological stains to a range of en-
vironmental conditions and performed mRNA profiling analy-
sis using eight different mRNA transcripts of selected house-
keeping and tissue-specific genes. The results demonstrated 
that RNA is detectable in some samples stored at room temper-
ature, even after 547 days, but heat and humidity appear to be 
detrimental to RNA stability.
　One of major advantages of body fluid identification by 
mRNA profiling is the possibility of simultaneous extraction of 
mRNA and DNA from the same stain, posing a major advant-
age in forensic investigations, where sample material is often 
limited. Actually, several optimized methods have been devel-
oped for simultaneously isolating mRNA and DNA from same 
physical stains (41, 42), and successful identification of the 
stain could be performed from the same stain where the do-
nor’s identity was confirmed (43, 44). Another important ad-
vantage of mRNA profiling is the possibility of detecting sev-
eral body fluids in one multiplex reaction, providing data on 
the expression of multiple genes simultaneously. 
　Various multiplexes have been reported, using reverse tran-
scription endpoint polymerase chain reaction (RT-PCR) meth-
ods and real-time quantitative reverse transcriptase-PCR 
(qRT-PCR) assay, including body fluid-specific markers (43-48). 
Since many transcripts are not completely tissue specific but 
usually show differences in expression level, qRT-PCR might 
be more appropriate for the detection of relative gene ex-
pression levels in different samples, and endpoint PCR might 
be suitable for the detection of certain transcripts with highly 
tissue-specific expression (48, 49).
　In 2005, Juusola and Ballantyne (45) proposed a multiplex 
RT-PCR method for the identification of body fluids that are 
commonly encountered in forensic casework. Using eight se-
lected body fluid-specific genes, i.e., β-spectrin (SPTB) and 
porphobilinogen deaminase (PBGD) for blood, statherin 
(STATH) and histatin 3 (HTN3) for saliva, protamine 1 (PRM1) 
and protamine 2 (PRM2) for semen, and human beta-defensin 
1 (HBD-1) and mucin 4 (MUC4) for vaginal secretions, they 
were able to detect each of the four body fluids as single or 
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Fig. 1. (A) Endpoint PCR multiplex 1 result of a blood-saliva-se-
men-vaginal secretion-menstrual blood mixture, revealing two 
peaks for each body fluid. Electropherograms of blood (B), vaginal 
secretion (C) and menstrual blood (D) samples detected with end-
point PCR multiplex 2. Reprinted from Haas et al. (48) with kind 
permission from Elsevier.
mixed stains. The sensitivity of the system was suitable for for-
ensic casework because successful identification of body fluids 
was possible with 200 pg-12 ng of input RNA. In the updated 
experiment in 2007, Juusola and Ballantyne (46) reported mul-
tiplex qRT-PCR assays for the identification of blood, saliva, se-
men, and menstrual blood. In this work, previously identified 
body fluid-specific genes were used for saliva and semen, but 
blood specific marker PBGD was replaced with δ-amino-
levulinate synthase 2 (ALAS2). In addition, matrix metal-
loproteinase 7 (MMP7) and matrix metalloproteinase 10 
(MMP10) were added for the detection of menstrual blood, 
and housekeeping gene GAPDH was introduced for the nor-
malization of the expression of body fluid-specific genes. 
Nussbaumer et al. (47) also reported multiplex qRT-PCR as-
says, which include hemoglobin A (HBA) for blood, kallikrein 
(KLK) for semen and mucin 4 (MUC4) for vaginal fluid or 
saliva. In the results, all semen samples showed a high ex-
pression of KLK mRNA, while none of other body fluids 
showed any expression of KLK. On the other hand, HBA 
mRNA was highly expressed in all blood samples screened, 
but some of the saliva samples also showed a weak reaction, 
while still being discriminative in expression level. Haas et al. 
(48) reported a multiplex RT-PCR and a multiplex qRT-PCR for 
the identification of blood, saliva, semen, menstrual blood and 
vaginal fluid using previously reported mRNA markers; SPTB, 
PBGD, STATH, HTN3, PRM1, PRM2, HBD1, MUC4, MMP7 
and MMP11 (Fig. 1). The two developed multiplex RT-PCRs 
showed high specificity, sensitivity and suitability for forensic 
body fluid analysis, and mRNA stability was demonstrated for 
up to 2-year-old stains. Recently, a collaborative exercise on 
mRNA profiling for the identification of blood was organized 
by the European DNA Profiling Group (EDNAP) (43), and the 
results demonstrated that all but one of the 16 participating 
laboratories were able to successfully isolate and detect blood 
specific-mRNA from the dried blood stains.
　Incidentally, several mRNA markers proposed for the identi-
fication of vaginal secretions show controversial results leading 
to false positives in saliva samples (45, 47, 50). Hence, 
Fleming and Harbison (51) suggested improving the mRNA 
multiplex system for body fluid identification by applying mi-
crobial markers for vaginal fluids. They have incorporated 
16S-23S rRNA intergenic spacer region (ISR) of Lactobacillus 
crispatus and Lactobacillus gasseri, reportedly predominant in 
the vagina of women, into previously described mRNA 
multiplex. From their results, the 16S-23S ISR of L. crispatus 
and L. gasseri were detected in vaginal secretions and in some 
menstrual blood samples but not in any other fluids, including 
blood, semen, and saliva. Although further works are needed 
for samples of various age ranges, this study provided the po-
tential use of vaginal bacteria as a tool for the identification of 
vaginal fluids.
MicroRNA profiling methods
Although a number of mRNA markers have been proposed as 
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sensitive and specific methods for forensic body fluid determi-
nation, and have also proven their stability successfully in sam-
ples over long periods of time, additional environmental con-
ditions such as humidity and temperature are expected to in-
fluence mRNA stability (39, 40). Therefore, recently, micro-
RNA (miRNA) markers have started to be explored as an alter-
native tool for forensic body fluid identification (52-54). 
MiRNAs are non-coding RNA molecules of 18 to 22 nucleo-
tides in length, and regulate gene expression at the post-tran-
scriptional level (55-57). Several recent studies have demon-
strated that many miRNAs showed tissue-specific expression 
patterns (58, 59). In addition, the intrinsically small size of 
miRNAs makes them less prone to degradation by environ-
mental factors, thus offering an obvious advantage as a useful 
biomarker for body fluid identification (52). In 2009, Hanson 
et al. (52) provided the first introduction of miRNA profiling to 
forensic science, and evaluated the miRNA expression in for-
ensically relevant biological fluids. In the study, they demon-
strated that miRNA can be extracted from forensic samples and 
examined the expression of 452 human miRNAs in blood, sali-
va, semen, vaginal secretions and menstrual blood using 
qRT-PCR analysis (miScript SYBR Green PCR kit, Qiagen). 
They have identified nine miRNAs-miR451, miR16, miR135b, 
miR10b, miR658, miR205, miR124a, miR372, and miR412- 
that are differentially expressed in forensic biological samples, 
and have proven their abilities to identify body fluid using as 
little as 50 pg of total RNA. Zubakov et al. (53) also profiled 
the expression levels of 718 miRNAs in forensically relevant 
body fluids using genome-wide microarrays and identified 14 
differentially expressed candidates for potential body-fluid 
identification. In the subsequent validation test using qRT-PCR, 
only blood and semen specific miRNA candidates showed 
comparable expression levels in microarray and qRT-PCR data, 
whereas less concordance was found for saliva, menstrual 
blood and vaginal secretions. Although these two initial stud-
ies showed the potential of miRNA profiling for forensic inves-
tigation, their results were inconsistent when different technol-
ogy platforms and statistical methods were applied. Therefore, 
it has been suggested that rigorous methodological validation 
and accurate models for data analysis are needed for accurate 
miRNA quantification in forensic applications (54).
DNA methylation profiling methods
Since recent whole-epigenome analyses indicated that DNA 
carries tissue-specific methylation patterns, the potential of tis-
sue-specific differential DNA methylation for body fluid identi-
fication has been examined in the forensic field (60-65). DNA 
methylation, which occurs at the 5'-position of the pyrimidine 
ring of cytosine in CpG dinucleotides, is generally believed to 
inhibit gene expression by affecting chromatin structure (66, 
67). Different cell types have different methylation patterns 
(68), and chromosome segments called tissue-specific differ-
entially methylated regions (tDMRs) are known to show differ-
ent DNA methylation profiles according to cell or tissue type 
(69, 70). Thus, detection of DNA methylation status at a cer-
tain CpG site of tDMR would allow for identification of the tis-
sue or cell type of DNA samples. 
　In 2011, Frumkin et al. (60) reported 15 genomic loci which 
are differentially methylated among blood (venous/menstrual), 
saliva, semen, skin epidermis, urine and vaginal secretion. In 
this study, they implemented an assay for selected markers us-
ing methylation-sensitive restriction enzyme-PCR (MSRE-PCR) 
made up of methylation-sensitive restriction enzyme digestion 
of sample DNA followed by multiplex PCR of specific ge-
nomic loci with fluorescence-labeled primers, capillary elec-
trophoresis of amplification products and automatic signal 
detection. The assay can be easily integrated into standardized 
procedures of forensic laboratories like DNA typing using 
short tandem repeat (STR), and could successfully identify 
source tissues in 50 DNA samples from blood, saliva, semen, 
and skin epidermis. Later, Wasserstrom et al. (63) advanced 
the previously reported approach by developing a kit, DNA 
source identifier (DSI)-SemenTM, which aims to replace micro-
scopic examination of sperm cells for forensic semen identi-
fication in casework samples. This assay is based on the de-
tection of semen-specific DNA methylation patterns in five ge-
nomic loci using MSRE-PCR. The kit was validated with 135 
samples of various body fluids and 33 actual casework sam-
ples from the forensic biological laboratory, and was proven to 
be robust and reliable by showing a positive result for semen 
given as little as 31 pg of template DNA input (63, 64). 
　Lee et al. (61) also examined the potential of tDMRs for for-
ensic body fluid identification using a bisulfite sequencing 
method. Bisulfite sequencing determines the DNA methylation 
status by detection of nucleotide base change due to sodium 
bisulfite treatment. Bisulfite treatment has no influence on me-
thylated cytosine, but converts free or unmethylated cytosine 
of CpG to uracil, which becomes thymine during subsequent 
PCR. Using this method, they produced methylation profiles 
for five tDMRs in pooled DNA samples from blood, saliva, se-
men, menstrual blood, and vaginal fluid. The tDMRs for 
DACT1 and USP49 were selected as a semen-specific marker 
by showing semen-specific hypomethylation, and the PFN3 
tDMR was suggested to be used for vaginal fluid identification. 
In a recent paper, An et al. (62) further investigated age-related 
methylation changes in semen-specific tDMRs using body flu-
ids from young and elderly man, since DNA methylation pat-
terns are known to be susceptible to change by aging (71,72). 
After confirming the stability of the body fluid-specific DNA 
methylation profile, they proposed two multiplex systems to 
analyze the methylation status of the USP49, DACT1, PRMT2 
and PFN3 tDMRs. The two multiplex systems were con-
structed using MSRE-PCR and methylation SNaPshot, and both 
could successfully identify semen with sperm cells and could 
distinguish menstrual blood and vaginal fluids from other body 
fluids in a test with 144 DNA samples (Fig. 2). Unlike MSRE- 
PCR, which shows only the amount of methylated CpGs, 
methylation SNaPshot has a merit that can measure the pro-
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Fig. 2. Typical DNA methylation pro-
files for samples from blood (A), sali-
va (B), menstrual blood (C), vaginal 
fluids (D) and semen (E) using MSRE- 
PCR (left) and methylation SNaPshot 
(right). Reprinted from An et al. (62) 
with kind permission from Springer 
Science + Business media.
portion of the methylated and/or unmethylated cytosine of the 
target CpG site simultaneously, because this assay is carried 
out by the amplification of bisulfite-converted DNA and sub-
sequent single base extension reaction. On the other hand, 
since genomic DNA can be degraded during bisulfite treat-
ment, a bisulfite-based methylation SNaPshot assay may con-
sume more samples than MSRE-PCR. Therefore, a sensitivity 
test was performed for the multiplex methylation SNaPshot, 
and the result showed that a minimum of 500 pg of starting ge-
nomic DNA, or 125 pg of bisulfite-converted DNA, was suffi-
cient for successful DNA methylation profiling of the selected 
tDMRs, which demonstrates the possible practical application 
of the multiplex system to forensic casework.
　A recent paper by Madi et al. (65) also reported tissue-spe-
cific DNA methylation in forensically relevant biological sam-
ples including blood, saliva, semen and epithelial cells. They 
examined a few genomic loci using bisulfite modification and 
pyrosequencing to find that the methylation patterns at the 
ZC3H12D and FGF7 loci can differentiate sperm from other 
biological samples while the C20orf117 locus and the BCAS4 
locus can differentiate blood and saliva from other samples, 
respectively. These results also indicate that the DNA methyl-
ation-based methods could be a valuable analysis tools for the 
characterization of forensically relevant biological fluids, but 
further validation studies including more markers will be re-
quired for actual casework applications.
CONCLUDING REMARKS
While current forensic DNA profiling based on STRs allows 
personal identification of biological sample donors, recent ad-
vances in forensics has suggested using other types of markers 
in order to add more informative layers to the evidence. 
Especially, various kinds of markers have been proposed for 
forensic body fluid identification. Among emerging techniques 
we have discussed, mRNA markers have been most rigorously 
investigated and the number of specific markers is sufficient 
for the identification of forensically relevant body fluids. Some 
of the other currently used methods have potential for the rap-
id and non-destructive identification of body fluids, but in 
most cases, tissue specificity is problematic due to cross re-
action with biological or non-biological material present in 
samples at crimes scene. On the other hand, mRNA markers 
show high tissue-specificity and adequate sensitivity for foren-
sic analysis, thereby being considered as a valuable new ap-
proach to overcome the limitations of conventional methods. 
However, mRNA profiling is not yet widely used in forensic 
laboratories probably owing to the fact that it does not allow 
for the simultaneous analysis of DNA profiling and body fluid 
identification. In addition, heat and humidity remain threats to 
the stability of mRNA markers. Recently, DNA methylation 
profiling was proposed as a promising new tool for forensic 
body fluid identification, which uses the same DNA samples 
which are used for DNA typing. Like mRNA profiling meth-
ods, DNA methylation profiling showed high specificity and 
sensitivity, and also allowed for the simultaneous analysis of 
multiple markers specific for various tissues in a single multi-
plex system. Moreover, DNA methylation profiling methods fit 
well with current forensic applications, and accordingly, can 
be easily integrated into forensic standardized procedures. 
However, excepting semen applications, DNA methylation 
still needs to identify more markers for future practical applica-
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tion to casework. We believe that it is now possible to identify 
more informative markers for body fluid identification using 
various high-throughput screening technologies. In the near fu-
ture, forensic investigations should improve a great deal be-
cause of the continued advances in genetics, epigenetics and 
molecular biology, and hence, the extraction of more in-
formation from forensically relevant biological samples will be 
possible.
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